What is the appropriate duration of amoxicillin‑clavulanate therapy for a wound infection?

Duration of Amoxicillin-Clavulanate for Wound Infections

For most wound infections, treat with amoxicillin-clavulanate for 5-7 days, with extension to 10-14 days only if there is significant surrounding cellulitis, deep tissue involvement, or immunocompromise.

Treatment Duration Framework

The IDSA guidelines 1 recommend amoxicillin-clavulanate as first-line therapy for bite wounds and infected wounds but do not specify exact duration. However, the evidence and clinical context allow us to construct a practical approach:

Standard Duration: 5-7 Days

• Uncomplicated wound infections (superficial, no extensive cellulitis, immunocompetent host)
• Most soft tissue infections respond within this timeframe
• Minimizes antibiotic exposure and adverse effects 2

Extended Duration: 10-14 Days

• Deep tissue involvement or significant surrounding cellulitis
• Hand, foot, or face wounds (higher risk anatomic sites per IDSA guidelines 1)
• Immunocompromised patients or those with diabetes
• Human bite wounds (higher bacterial load and complexity 1)

Prophylactic/Early Treatment: 3-5 Days

• Animal bites presenting 9-24 hours post-injury benefit from prophylaxis 3
• Wounds <9 hours old show minimal benefit from prophylaxis unless high-risk (hand/foot/face, immunocompromised, or involving joints/tendons) 3

Key Evidence Considerations

The available evidence reveals important gaps:

• No specific duration studies for wound infections: The IDSA guidelines 1 provide antibiotic selection but not duration specifics for wound infections
• Extrapolation from related conditions: Studies in diabetic foot infections used median 30 days 4, but these are more complex than typical wound infections
• Surgical prophylaxis data: Short-duration perioperative prophylaxis (≤24 hours) is sufficient for preventing surgical site infections 5, 6, suggesting brief courses are effective when source control is achieved
• Respiratory infection data: A 2-week course was non-inferior to 4 weeks for protracted bacterial bronchitis 7, supporting shorter durations when clinically appropriate

Dosing Specifics

• Standard adult dose: 875/125 mg twice daily 1
• Take with food to reduce gastrointestinal upset 2
• Complete the full course even if symptoms improve early 2

Critical Pitfalls to Avoid

1. Over-treatment: Extending therapy beyond 7 days without clear indication increases adverse effects (diarrhea, C. difficile risk) and antimicrobial resistance 5

2. Under-treatment of high-risk wounds: Hand, foot, and face wounds require longer courses due to higher complication rates 1

3. Ignoring source control: Antibiotics alone are insufficient if there is undrained purulence or retained foreign material—debridement is essential

4. Missing MRSA: Amoxicillin-clavulanate does not cover MRSA 1. If purulent infection with concern for MRSA (especially in areas with high community prevalence), add coverage or switch agents

5. Inadequate wound care: Proper irrigation, debridement, and wound management are as important as antibiotic selection 1

Clinical Decision Algorithm

Step 1: Assess wound characteristics

• Superficial vs. deep
• Purulent vs. non-purulent
• Anatomic location (hand/foot/face = high-risk)
• Time since injury

Step 2: Assess host factors

• Immunocompetent vs. immunocompromised
• Diabetes or vascular disease present

Step 3: Determine duration

• 5-7 days: Superficial, non-purulent, immunocompetent, non-high-risk location
• 10-14 days: Deep involvement, extensive cellulitis, high-risk location, or immunocompromised
• 3-5 days: Prophylaxis for animal bites 9-24 hours old

Step 4: Ensure adequate source control

• Drain abscesses
• Debride devitalized tissue
• Remove foreign bodies

Step 5: Reassess at 48-72 hours

• If worsening or no improvement, consider imaging, cultures, and alternative diagnoses (including MRSA coverage)